Exclusion screening for pharmacies & PBMs

Part D and Medicaid leave almost no pharmacy out of scope

Pharmacy is one of the most government-funded corners of healthcare. Medicare Part D benefit spending is projected near $141 billion for 2026, roughly 11% of all Medicare benefits, and that money reaches patients one filled script at a time across more than 40,000 pharmacy and drug-store businesses. Layer state Medicaid on top, where pharmacy is a core benefit in every state, and the practical result is simple: if you dispense, you bill federal and state programs, and if you bill those programs, exclusion screening is not optional. The question is never whether a pharmacy has to screen. It is whether the pharmacy is screening everything the rules actually reach.

The prescriber on the script is your exposure, not only your staff

This is the part of the rule pharmacies most often miss. The OIG's Special Advisory Bulletin on the Effect of Exclusion states plainly that no federal program will pay for an item furnished on the prescription of an excluded person when the dispenser knew or should have known about the exclusion. A pharmacy, the bulletin says, should confirm at the point of service that the prescriber is not excluded before the item is provided. It even warns that a valid license number or DEA number tells you nothing about exclusion status. Most pharmacies screen their own employees and stop there, which leaves the prescriber network, the larger and faster-moving population, completely unchecked. Provider Signals lets you load the providers whose scripts you fill and catches an excluded or deactivated prescriber before the claim goes out.

Owners, the pharmacist-in-charge, and every technician are counted

The payment prohibition follows the work, not the job title. The same OIG guidance is explicit that excluded individuals who key in prescription information for billing, or who fill prescriptions billed to federal programs, fall squarely inside it. In practice that means the owner, the pharmacist-in-charge who carries legal accountability for the dispensing operation, every staff pharmacist, every technician at the data-entry and adjudication step, plus delivery, billing, and contracted staff all belong on one roster. Enforcement reaches small operators, not just chains. A pharmacist in Minnesota settled for about $96,000 after owning and managing a pharmacy while excluded; a Brooklyn pharmacy paid roughly $204,000 when an excluded pharmacist's services were billed to federal programs; and Rx Plus Pharmacy paid $15,000 for employing a single excluded individual.

What one overlooked name actually costs

An exclusion is absolute. No federal health program pays for any item or service furnished by an excluded person, directly or indirectly, and the penalty structure under 42 CFR 1003.210 stacks quickly for a high-volume dispenser:

• Up to $20,000 in civil money penalties per item or service tied to the excluded person, and a busy counter bills thousands of line items a month.
• Assessments of up to three times the amount claimed.
• Overpayment recovery on everything the excluded person touched, with False Claims Act liability layered on top.

Because so much pharmacy revenue is Medicaid, the state Medicaid exclusion lists matter as much as the federal LEIE. A name can land on a state sanction list, SAM.gov, or Medicare Opt-Out without ever appearing on the LEIE, so a single-source check is a blind spot. That all-state coverage is what most screening tools sell as a paid upgrade. On Provider Signals it ships on every plan, Free included.

PBM credentialing, Medicaid revalidation, and Part D audits arrive on their own schedule

Screening is not only an OIG obligation. PBM network contracts require ongoing sanction and exclusion checks as a condition of staying in-network, Medicaid programs run periodic revalidation, and Part D plan sponsors and CMS conduct their own audits of the pharmacies in their networks. Each of those reviews asks the same thing: show us the dated proof that you screened, when, and against what. Provider Signals keeps a timestamped, exportable record of every screen for every person and prescriber on your roster, so a PBM audit request or a Medicaid revalidation packet is an export rather than a fire drill.

Where Provider Signals beats the legacy vendors

The established exclusion-screening platforms are enterprise-priced, often $15,000 to $200,000 a year, and they still tend to bill all-state Medicaid coverage as an add-on. For an independent pharmacy or a regional chain that math rarely works. Provider Signals delivers the same continuous, all-source monitoring as a self-serve product, priced to the size of your roster.

The OIG expects a check at hire and at least monthly after that. Provider Signals runs it continuously instead, so a new match surfaces the day it lands rather than at the next batch. See how the engine works on the exclusion screening overview, compare other segments on the industry hub, or size your roster on the pricing page.

How we match your roster

Exclusion screening is only as good as its matching. We match each person or entity against every source using the full identifier set together — NPI, first name, last or organization name, city, state, and ZIP — never one field alone. NPI alone misses records (the OIG LEIE and many lists don’t carry an NPI for every entry); a name or a location alone produces false matches on common names. When a source record has no NPI, we fall back to name plus location.

Because accuracy depends on your input, provide complete, correct details for every roster entry. When more than one possible match is found, we show you all candidates with their source records so you can confirm, select, or merge — we never auto-flag anyone as excluded. Always verify a match against the primary source before taking any action.

Frequently asked questions